Transplantation of Human Umbilical Mesenchymal Stem Cells from Wharton's Jelly after Complete Transection of the Rat Spinal Cord
Open Access
- 6 October 2008
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 3 (10), e3336
- https://doi.org/10.1371/journal.pone.0003336
Abstract
Human umbilical mesenchymal stem cells (HUMSCs) isolated from Wharton's jelly of the umbilical cord can be easily obtained and processed compared with embryonic or bone marrow stem cells. These cells may be a valuable source in the repair of spinal cord injury. We examine the effects of HUMSC transplantation after complete spinal cord transection in rats. Approximately 5×105 HUMSCs were transplanted into the lesion site. Three groups of rats were implanted with either untreated HUMSCs (referred to as the stem cell group), or HUMSCs treated with neuronal conditioned medium (NCM) for either three days or six days (referred to as NCM-3 and NCM-6 days, respectively). The control group received no HUMSCs in the transected spinal cord. Three weeks after transplantation, significant improvements in locomotion were observed in all the three groups receiving HUMSCs (stem cell, NCM-3 and NCM-6 days groups). This recovery was accompanied by increased numbers of regenerated axons in the corticospinal tract and neurofilament-positive fibers around the lesion site. There were fewer microglia and reactive astrocytes in both the rostral and caudal stumps of the spinal cord in the stem cell group than in the control group. Transplanted HUMSCs survived for 16 weeks and produced large amounts of human neutrophil-activating protein-2, neurotrophin-3, basic fibroblast growth factor, glucocorticoid induced tumor necrosis factor receptor, and vascular endothelial growth factor receptor 3 in the host spinal cord, which may help spinal cord repair. Transplantation of HUMSCs is beneficial to wound healing after spinal cord injury in rats.This publication has 66 references indexed in Scilit:
- Islet-Like Clusters Derived from Mesenchymal Stem Cells in Wharton's Jelly of the Human Umbilical Cord for Transplantation to Control Type 1 DiabetesPLOS ONE, 2008
- Mesenchymal Stem Cells from Rat Bone Marrow Downregulate Caspase-3-mediated Apoptotic Pathway After Spinal Cord Injury in RatsNeurochemical Research, 2007
- The long-term neurocompatibility of human fibrin sealant and equine collagen as biomatrices in experimental spinal cord injuryExperimental and Toxicologic Pathology, 2007
- Inflammation and spinal cord injury: Infiltrating leukocytes as determinants of injury and repair processesClinical Neuroscience Research, 2006
- Transplants of Human Mesenchymal Stem Cells Improve Functional Recovery After Spinal Cord Injury in the RatCellular and Molecular Neurobiology, 2006
- Glial nitric oxide and ischemiaGlia, 2005
- Mesenchymal Stem Cells in the Wharton's Jelly of the Human Umbilical CordThe International Journal of Cell Cloning, 2004
- In vitro differentiation of transplantable neural precursors from human embryonic stem cellsNature Biotechnology, 2001
- Basic Fibroblast Growth Factor (bFGF) Enhances Functional Recovery Following Severe Spinal Cord Injury to the RatExperimental Neurology, 2000
- Better cells for brain repairNature, 1993